Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2021-01, Vol.12, p.609508-609508
Main Authors: Vorobjeva, Nina V, Sud'ina, Galina F, Chernyak, Boris V
Format: Article
Language:English
Subjects:
COVID-19
mitochondria
NADPH oxidase
neutrophils
Pharmacology
pneumonia
reactive oxygen species
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2021.609508